E34.322

Clinical Causes: Genetic mutations affecting the IGF-1 receptor (IGF-1R). Defects in post-receptor signaling pathways that disrupt normal IGF-1 function. Inherited syndromes that involve resistance to IGF-1 signaling. Rarely, environmental or acquired factors that may influence IGF-1 activity.

Key Symptoms: Delayed growth and short stature compared to peers. Reduced muscle development and strength. Hypoglycemia (low blood sugar levels), especially during fasting. Delayed or abnormal bone development. Possible intellectual or developmental delays in some cases. Signs associated with specific syndromic features depending on the genetic mutation involved.

Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, and specialized tests. Key approaches include: - Blood tests measuring IGF-1 levels, which may be low or abnormal. - Genetic testing to identify mutations in the IGF-1 receptor gene or related pathways. - Imaging studies such as X-rays to assess bone growth. - Functional tests to evaluate the body's response to IGF-1 administration. Given the rarity of the condition, diagnosis often involves a multidisciplinary team of specialists in genetics, endocrinology, and pediatrics.

Treatment Protocols: Currently, there is no cure for IGF-1 resistance, but treatment strategies aim to support growth and development and manage symptoms: - Growth hormone therapy may be considered in some cases, although its effectiveness varies. - Nutritional support and addressing metabolic issues such as hypoglycemia. - Regular monitoring of growth parameters and developmental progress. - Supportive therapies, including physical therapy or developmental interventions, to assist with growth and cognitive development. - Ongoing medical follow-up is essential to adjust treatments and address associated health concerns.